CIA
DNA icon

Cape Investment Advisory’s Ginkgo Bioworks DNA Stock Holding History

Cape Investment Advisory’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12
Closed -$175 – 1318
2025
Q3 		$175 Hold
12
– – ﹤0.01% 823
2025
Q2 		$135 Hold
12
– – ﹤0.01% 1134
2025
Q1 		$68 Hold
12
– – ﹤0.01% 1112
2024
Q4 		$118 Hold
12
– – ﹤0.01% 1082
2024
Q3 		$98 Sell
12
-1
-8% -$10 ﹤0.01% 941
2024
Q2 		$167 Sell
13
-250
-95% -$7.46K ﹤0.01% 902
2024
Q1 		$12.2K Buy
263
+250
+1,923% +$12.9K 0.01% 514
2023
Q4 		$845 Hold
13
– – ﹤0.01% 1028
2023
Q3 		$905 Hold
13
– – ﹤0.01% 842
2023
Q2 		$930 Buy
+13
New +$770 ﹤0.01% 831

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cape Investment Advisory's DNA Position: Q4 2025 in Review

Cape Investment Advisory sold out of Ginkgo Bioworks (DNA) in Q4 2025, closing a stake of 12 shares — an estimated $175 sold.

Cape Investment Advisory first reported a position in DNA in Q2 2023 and held it in 10 quarters. The position peaked at $12.2K in Q1 2024. 181 funds tracked by Wall St. Rank hold DNA as of Q4 2025.

  • Cape Investment Advisory reported no remaining Ginkgo Bioworks position as of Q4 2025 after selling out during the quarter.
  • Cape Investment Advisory sold 12 Ginkgo Bioworks shares in Q4 2025, an estimated $175.
  • Cape Investment Advisory first reported a position in Ginkgo Bioworks in Q2 2023 and held it in 10 quarters.
  • Cape Investment Advisory's Ginkgo Bioworks position peaked at $12.2K in Q1 2024.
  • 181 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.

Based on Cape Investment Advisory's 13F filing for Q4 2025, filed 17 Feb 2026.